Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edonia is a Paris-based biotechnology company that transforms microalgae into a sustainable, nutrient-rich meat alternative. The company employs a proprietary Edonization process to convert microalgae biomass into a textured ingredient that replicates the sensory experience of meat without the need for heavy processing or additives. By leveraging the high protein content and complete amino acid profile of microalgae, Edonia provides food manufacturers with a low-carbon, clean-label solution for the next generation of plant-based foods. Their technology preserves essential nutrients like B12, iron, and omega-3s, addressing both environmental sustainability and human nutrition. The company is currently scaling its production capabilities to meet the increasing global demand for high-quality alternative proteins.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edonia.